IL-4 significantly inhibited cell cycle G1-S-phase progression.
IL-4顯著抑制細胞週期G1-S期進展。
IL-4 was found to induce an unphosphorylated form of retinoblastoma gene product (Rbp) within 24 h and significantly reduce the phosphorylated form at 48 h.
發現IL-4在24小時內誘導視網膜母細胞瘤基因產物(Rbp)的未磷酸化形式,並在48小時顯著降低磷酸化形式。
IL-4 down-regulated p34cdc2, a kinase associated with Rbp phosphorylation and cyclin D1.
IL-4下調p34cdc2,與Rbp磷酸化和細胞週期蛋白D1相關的激酶。
Cyclin D1, considered as a critical nuclear regulatory factor of G0-G1 to S-phase transition was down-regulated 24 and 48 h post-IL-4 treatment as well.
細胞週期蛋白D1被認為是G0-G1至S期轉移的關鍵核調節因子,也在IL-4治療後24和48小時下調。
小結1:
要形成癌細胞,就必須經過磷酸化,而IL-4可以降低與磷酸化有關及細胞週期蛋白。
We have previously demonstrated that interleukin-2 (IL-2) receptors, IL-2 protein, and mRNA for IL-2 are
present in human carcinomas in vitro and in vivo.
我們以前已經證明,白介素-2(IL-2)受體,IL-2蛋白和IL-2的mRNA在體外和體內存在於人類癌中。
Carcinoma cells synchronized in the G2/M-phase of the cell cycle express significantly more intracytoplasmic
IL-2 as well as IL-2R-beta and -gamma than tumor cells in the G0/G1-phase.
在G0 / G1期的腫瘤細胞中,在細胞週期的G2 / M期同步的癌細胞比腫瘤細胞表達明顯更多的細胞質內IL-2以及IL-2R-β和γ。
All tumor cell lines were shown to express IL-2 in the Golgi complex.
所有腫瘤細胞係都顯示在高爾基複合體中表達IL-2。
The strongest IL-2 expression was seen in tumor cells undergoing mitosis
在接受有絲分裂的腫瘤細胞中觀察到最強的IL-2表達
In the tumor tissue, the highest level of co-expression of IL-2 and Ki-67 was observed
in poorly differentiated carcinomas
在腫瘤組織中,在分化不良的癌中(癌細胞很難生長)觀察到最高水平的IL-2和Ki-67的共表達
Well-differentiated carcinomas showed a significantly lower expression of both proteins
(LI 35.0% for IL-2 and 26.5% for Ki-67).
分化良好的癌症(癌細胞正常生長)顯示兩種蛋白質的表達明顯降低(IL-2為35.3%,Ki-67為26.5%)。
小結2:
因此,如果體內IL-2表達足夠的話,是不會產生癌細胞的;體內IL-2夠多也代表免疫力夠強,因此才有免疫力和癌症的關聯性的說法。
STAT3 was rapidly phosphorylated both in cells with wildtype or variant IL10R1
and maintained phosphorylated when cells were cultured with IL-10.
STAT3在具有野生型或變體IL10R1的細胞中迅速磷酸化,當細胞用IL-10培養時,STAT3被磷酸化。
Among them, STAT3 is a major player, aberrant activation of which is
involved in several diseases, including cancer.
其中,STAT3是主要參與者,其異常激活是涉及幾種疾病,包括癌症。
which has been associated with breast,
ovarian and prostate cancer, induced constitutive phosphorylation of STAT3
與乳癌,卵巢癌和前列腺癌有關,誘導STAT3的組成型磷酸化
Down-regulation of IL-17 by IL-4 is dependent on STAT6 and mediated by inhibition of STAT3
IL-4對IL-17的下調依賴於STAT6,並通過抑制STAT3來介導(→IL-4可以抑制STAT3)
小結3:因此會造成STAT3磷酸化的IL-10無法用來對抗癌細胞,而IL-4可以抑制STAT3。
總結以上:
西醫的癌細胞免疫療法
除了注射IL-2之外
應該還要注射IL-4而不是IL-10
營養裡能夠產生IL-4的是:鋅、維生素A、兒茶素、茄紅素、薑黃素、黃酮類化合物(蜂膠黃酮、生物類黃酮、大豆異黃酮)、鞣花酸